• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.能量平衡、mTOR 通路中的多态性与肾细胞癌风险。
J Natl Cancer Inst. 2013 Mar 20;105(6):424-32. doi: 10.1093/jnci/djt005. Epub 2013 Feb 2.
2
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.能量平衡、PI3K-AKT-mTOR 通路基因与膀胱癌风险。
Cancer Prev Res (Phila). 2010 Apr;3(4):505-17. doi: 10.1158/1940-6207.CAPR-09-0263. Epub 2010 Mar 30.
3
A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk.MTOR 启动子中的功能变体调节其表达,并与肾细胞癌风险相关。
PLoS One. 2012;7(11):e50302. doi: 10.1371/journal.pone.0050302. Epub 2012 Nov 28.
4
The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.肥胖及体重波动在肾细胞癌病因学中的作用:一项基于人群的病例对照研究。
Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):631-9.
5
Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.mTOR通路中的基因变异以及非裔美国人和欧裔美国女性中其与体型和体重增加对乳腺癌风险的相互作用。
Cancer Causes Control. 2016 Aug;27(8):965-76. doi: 10.1007/s10552-016-0774-x. Epub 2016 Jun 17.
6
Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.全基因组关联研究鉴定的易感位点与饮食模式联合与非西班牙裔白人患肾细胞癌风险的相关性。
Am J Epidemiol. 2014 Sep 1;180(5):499-507. doi: 10.1093/aje/kwu158. Epub 2014 Jul 22.
7
MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk.VHL-HIF1α 通路中的 microRNA 靶位点多态性预测肾细胞癌风险。
Mol Carcinog. 2014 Jan;53(1):1-7. doi: 10.1002/mc.21917. Epub 2012 Apr 19.
8
Variants in blood pressure genes and the risk of renal cell carcinoma.血压基因变异与肾细胞癌风险。
Carcinogenesis. 2010 Apr;31(4):614-20. doi: 10.1093/carcin/bgp321. Epub 2010 Jan 4.
9
Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study.身高、体重、能量摄入及身体活动与肾细胞癌风险的关系:荷兰队列研究结果
Am J Epidemiol. 2004 Dec 15;160(12):1159-67. doi: 10.1093/aje/kwh344.
10
Body mass index, physical activity, and risk of renal cell carcinoma.体重指数、身体活动与肾细胞癌风险
Int J Obes (Lond). 2006 Jun;30(6):940-7. doi: 10.1038/sj.ijo.0803231.

引用本文的文献

1
mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.mTOR 通路候选基因与黑人女性中体力活动对乳腺癌风险的交互作用:妇女健康研究的循环分析。
Breast Cancer Res Treat. 2023 May;199(1):137-146. doi: 10.1007/s10549-023-06902-6. Epub 2023 Mar 8.
2
Folliculin-interacting protein FNIP2 impacts on overweight and obesity through a polymorphism in a conserved 3' untranslated region.FNIP2 与卵泡抑素相互作用蛋白通过一个保守的 3'非翻译区的多态性影响超重和肥胖。
Genome Biol. 2022 Oct 31;23(1):230. doi: 10.1186/s13059-022-02798-5.
3
The current state of genetic risk models for the development of kidney cancer: a review and validation.当前用于肾癌发生的遗传风险模型的研究现状:综述与验证。
BJU Int. 2022 Nov;130(5):550-561. doi: 10.1111/bju.15752. Epub 2022 May 7.
4
Renal Cell Cancer and Obesity.肾细胞癌与肥胖。
Int J Mol Sci. 2022 Mar 21;23(6):3404. doi: 10.3390/ijms23063404.
5
Polymorphisms in the mTOR-PI3K-Akt pathway, energy balance-related exposures and colorectal cancer risk in the Netherlands Cohort Study.荷兰队列研究中mTOR-PI3K-Akt信号通路的多态性、能量平衡相关暴露因素与结直肠癌风险
BioData Min. 2022 Jan 10;15(1):2. doi: 10.1186/s13040-021-00286-3.
6
[Risk-adapted (immuno)therapy for renal cell carcinoma].[肾细胞癌的风险适应性(免疫)治疗]
Urologe A. 2018 Nov;57(11):1326-1333. doi: 10.1007/s00120-018-0791-3.
7
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.降低肾细胞癌发病率的可改变风险因素:来自前列腺、肺癌、结直肠癌和卵巢癌(PLCO)试验的见解。
Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17.
8
Physical Activity Decreases Kidney Cancer Mortality.体育活动可降低肾癌死亡率。
Curr Urol. 2017 Nov;10(4):193-198. doi: 10.1159/000447180. Epub 2017 Oct 22.
9
Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes.靶向肥胖相关基因鉴定肾细胞癌的潜在易感性位点。
Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1436-1442. doi: 10.1158/1055-9965.EPI-17-0141. Epub 2017 Jun 16.
10
The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis.血管内皮生长因子的五种多态性与肾细胞癌风险之间的关联:一项更新的荟萃分析。
Onco Targets Ther. 2017 Mar 21;10:1725-1734. doi: 10.2147/OTT.S125965. eCollection 2017.

本文引用的文献

1
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
2
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.全基因组关联研究鉴定出 12p11.23 上肾细胞癌的新易感位点。
Hum Mol Genet. 2012 Jan 15;21(2):456-62. doi: 10.1093/hmg/ddr479. Epub 2011 Oct 18.
3
Renal cell cancer among African Americans: an epidemiologic review.非裔美国人的肾细胞癌:流行病学综述。
BMC Cancer. 2011 Apr 12;11:133. doi: 10.1186/1471-2407-11-133.
4
mTOR: from growth signal integration to cancer, diabetes and ageing.mTOR:从生长信号整合到癌症、糖尿病和衰老。
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. doi: 10.1038/nrm3025. Epub 2010 Dec 15.
5
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.代谢信号通路中遗传变异与结直肠癌风险:mTOR、PTEN、STK11、RPKAA1、PRKAG2、TSC1、TSC2、PI3K 和 Akt1。
Carcinogenesis. 2010 Sep;31(9):1604-11. doi: 10.1093/carcin/bgq142. Epub 2010 Jul 9.
6
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.mTORC1 介导的细胞增殖,而非细胞生长,受 4E-BPs 调控。
Science. 2010 May 28;328(5982):1172-6. doi: 10.1126/science.1187532.
7
The genetic basis of kidney cancer: a metabolic disease.肾癌的遗传基础:一种代谢疾病。
Nat Rev Urol. 2010 May;7(5):277-85. doi: 10.1038/nrurol.2010.47.
8
Epidemiology and risk factors for kidney cancer.肾癌的流行病学和危险因素。
Nat Rev Urol. 2010 May;7(5):245-57. doi: 10.1038/nrurol.2010.46.
9
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.能量平衡、PI3K-AKT-mTOR 通路基因与膀胱癌风险。
Cancer Prev Res (Phila). 2010 Apr;3(4):505-17. doi: 10.1158/1940-6207.CAPR-09-0263. Epub 2010 Mar 30.
10
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.对致癌 mTOR 通路的遗传剖析揭示了通过 4EBP-eIF4E 进行药物成瘾的翻译控制。
Cancer Cell. 2010 Mar 16;17(3):249-61. doi: 10.1016/j.ccr.2010.01.021.

能量平衡、mTOR 通路中的多态性与肾细胞癌风险。

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

机构信息

Department of Epidemiology, Unit 1340, University of Texas MD Anderson Cancer Center, 1155 Pressler Blvd, Houston, TX 77030, USA.

出版信息

J Natl Cancer Inst. 2013 Mar 20;105(6):424-32. doi: 10.1093/jnci/djt005. Epub 2013 Feb 2.

DOI:10.1093/jnci/djt005
PMID:23378641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3601952/
Abstract

BACKGROUND

The interplay between obesity, physical activity, weight gain, and genetic variants in the mTOR pathway has not been studied in renal cell carcinoma (RCC). We examined the associations between obesity, weight gain, physical activity, and RCC risk. We also analyzed whether genetic variants in the mTOR pathway could modify the association.

METHODS

Incident RCC case subjects and healthy control subjects were recruited from the University of Texas MD Anderson Cancer Center in Houston, Texas. Case subjects and control subjects were frequency matched. Epidemiologic data were collected by in-person interview. One hundred ninety single nucleotide polymorphisms (SNPs) from 22 genes in the mTOR pathway were extracted from previous genome-wide association studies. Logistic regression and regression spline were performed to obtain odds ratios (ORs). All statistical tests were two-sided.

RESULTS

A total of 577 non-Hispanic white case subjects and 593 healthy control subjects were included. Obesity at age 20 years (OR = 1.92, 95% confidence interval [CI] = 1.05 to 3.50; P = .03) and age 40 years (OR = 2.03, 95% CI = 1.38 to 2.98; P < .001) and moderate (OR = 1.46, 95% CI = 1.02 to 2.09; P = .04) and massive weight gain (OR = 1.62, 95% CI = 1.10 to 2.39; P = .01) from age 20 to 40 years were each statistically significantly associated with increased RCC risk. Low physical activity was associated with a 4.08-fold increased risk. Among 190 SNPs in the mTOR pathway, six SNPs located in the AKT3 gene were statistically significantly associated with increased risk, and those with three or more unfavorable genotypes had a 1.72-fold increased risk of RCC.

CONCLUSION

Obesity, weight gain, physical activity, and genetic variants in the mTOR pathway may individually and jointly influence susceptibility to RCC.

摘要

背景

肥胖、体力活动、体重增加和 mTOR 通路中的遗传变异之间的相互作用尚未在肾细胞癌 (RCC) 中进行研究。我们检查了肥胖、体重增加、体力活动与 RCC 风险之间的关联。我们还分析了 mTOR 通路中的遗传变异是否可以改变这种关联。

方法

来自德克萨斯州休斯顿的德克萨斯大学 MD 安德森癌症中心的 RCC 病例和健康对照被招募。病例和对照按频率匹配。通过面对面访谈收集流行病学数据。从之前的全基因组关联研究中提取了 mTOR 通路中的 22 个基因中的 190 个单核苷酸多态性 (SNP)。使用逻辑回归和回归样条获得比值比 (OR)。所有统计检验均为双侧。

结果

共纳入 577 名非西班牙裔白人病例和 593 名健康对照。20 岁时肥胖 (OR = 1.92,95%置信区间 [CI] = 1.05 至 3.50;P =.03) 和 40 岁时肥胖 (OR = 2.03,95% CI = 1.38 至 2.98;P <.001) 以及从 20 岁到 40 岁之间的中度 (OR = 1.46,95% CI = 1.02 至 2.09;P =.04) 和大量体重增加 (OR = 1.62,95% CI = 1.10 至 2.39;P =.01) 均与 RCC 风险增加有统计学意义。体力活动不足与风险增加 4.08 倍相关。在 mTOR 通路中的 190 个 SNP 中,位于 AKT3 基因中的 6 个 SNP 与增加的风险有统计学意义,并且具有三个或更多不利基因型的患者患 RCC 的风险增加 1.72 倍。

结论

肥胖、体重增加、体力活动和 mTOR 通路中的遗传变异可能单独和共同影响 RCC 的易感性。